Dobrin Nedelkov Selected Research

Type 2 Diabetes Mellitus (MODY)

10/2017	Mass Spectrometric Studies of Apolipoprotein Proteoforms and Their Role in Lipid Metabolism and Type 2 Diabetes.
7/2016	Posttranslational modifications of apolipoprotein A-II proteoforms in type 2 diabetes.
1/2016	Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes.
1/2015	Serum amyloid a truncations in type 2 diabetes mellitus.
3/2011	Quantitative mass spectrometry evaluation of human retinol binding protein 4 and related variants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dobrin Nedelkov Research Topics

Disease

5	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 12/2014
5	Type 2 Diabetes Mellitus (MODY) 10/2017 - 03/2011
4	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 03/2003
3	Atherosclerosis 01/2023 - 01/2016
3	Myocardial Infarction 01/2023 - 02/2003
2	Amyloidosis 01/2023 - 12/2022
2	Obesity 01/2017 - 01/2015
2	Chronic Renal Insufficiency 11/2016 - 01/2016
2	Neoplasms (Cancer) 04/2013 - 10/2006
2	Pathologic Processes 04/2011 - 07/2007
2	Disease Progression 04/2011 - 06/2005
1	Heart Arrest (Cardiac Arrest) 01/2023
1	Coronary Disease (Coronary Heart Disease) 01/2023
1	Stroke (Strokes) 01/2023
1	Sjogren's Syndrome (Sjogren Syndrome) 12/2022
1	Cardiomyopathies (Cardiomyopathy) 12/2022
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Immunoglobulin Light-chain Amyloidosis 06/2018
1	Hypoglycemia (Reactive Hypoglycemia) 01/2018
1	Weight Loss (Weight Reduction) 01/2017
1	Prediabetic State (Prediabetes) 01/2016
1	Glucose Intolerance 01/2016
1	Hypertriglyceridemia 01/2016
1	Inflammation (Inflammations) 02/2015
1	Growth Disorders 01/2013
1	Insulin Resistance 03/2011
1	Rheumatoid Arthritis 11/2010
1	Kidney Diseases (Kidney Disease) 11/2010
1	Amyloid Plaque 06/2004

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2013 - 02/2003
6	Proteins (Proteins, Gene)FDA Link 12/2022 - 06/2005
6	Apolipoprotein C-IIIIBA 01/2020 - 01/2015
4	Apolipoproteins C (ApoC)IBA 01/2023 - 01/2016
3	LipidsIBA 01/2023 - 01/2016
3	Apolipoproteins E (ApoE)IBA 01/2023 - 03/2003
3	Cystatin CIBA 11/2016 - 04/2011
2	ApolipoproteinsIBA 01/2023 - 10/2017
2	Protein Isoforms (Isoforms)IBA 01/2021 - 04/2013
2	Apolipoprotein E4IBA 01/2021 - 01/2020
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2017 - 12/2014
2	Triglycerides (Triacylglycerol)IBA 10/2017 - 01/2017
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2015 - 02/2003
2	Blood Proteins (Serum Proteins)IBA 06/2004 - 02/2003
1	CalciumIBA 01/2023
1	Proline (L-Proline)FDA Link 12/2022
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	Apolipoprotein C-I (Apolipoprotein C1)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2017
1	oxidized low density lipoproteinIBA 01/2017
1	CarbohydratesIBA 01/2017
1	Hydroxyproline (4 Hydroxyproline)IBA 11/2016
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 07/2016
1	Serine (L-Serine)FDA Link 01/2016
1	Pioglitazone (Actos)FDA Link 01/2016
1	ChemokinesIBA 02/2015
1	Chemokine CCL5IBA 02/2015
1	Methionine (L-Methionine)FDA Link 12/2014
1	Insulin-Like PeptidesIBA 01/2013
1	Cysteine Proteinase InhibitorsIBA 04/2011
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 03/2011
1	ProteomeIBA 07/2007
1	Serum Amyloid P-ComponentIBA 06/2004

Therapy/Procedure

2	Therapeutics 04/2011 - 06/2005
1	Organ Transplantation 12/2022
1	Glycemic Control 01/2016